Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitors

Published:2020-08-31 Issue:9 Volume:1 Page:894-908
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Keshet Rom,Lee Joo Sang^ORCID,Adler Lital,Iraqi Muhammed,Ariav Yarden,Lim Lisha Qiu Jin,Lerner Shaul,Rabinovich Shiran,Oren Roni,Katzir Rotem,Weiss Tishler Hila,Stettner Noa,Goldman Omer,Landesman Hadas,Galai Sivan,Kuperman Yael,Kuznetsov Yuri,Brandis Alexander,Mehlman Tevi,Malitsky Sergey,Itkin Maxim,Koehler S. Eleonore,Zhao Yongmei,Talsania Keyur,Shen Tsai-wei,Peled Nir,Ulitsky Igor^ORCID,Porgador Angel,Ruppin Eytan,Erez Ayelet^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s43018-020-0106-7.pdf

Reference58 articles.

1. Husson, A., Brasse-Lagnel, C., Fairand, A., Renouf, S. & Lavoinne, A. Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle. Eur. J. Biochem. 270, 1887–1899 (2003).

2. Erez, A., Nagamani, S. C. & Lee, B. Argininosuccinate lyase deficiency-argininosuccinic aciduria and beyond. Am. J. Med. Genet. 157, 45–53 (2011).

3. Liu, Q. et al. Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma. PLoS ONE 12, e0171985 (2017).

4. Sahu, D. et al. Argininosuccinate synthetase 1 loss in invasive bladder cancer regulates survival through general control nonderepressible 2 kinase-mediated eukaryotic initiation factor 2α activity and is targetable by pegylated arginine deiminase. Am. J. Pathol. https://doi.org/10.1016/j.ajpath.2016.09.004 (2016).

5. Kim, Y. et al. Reduced argininosuccinate synthetase expression in refractory sarcomas: impacts on therapeutic potential and drug resistance. Oncotarget 7, 70832–70844 (2016).

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic profiling identifies a nucleotide metabolism-related signature with prognostic power in gliomas;Translational Oncology;2024-11

2. Long-term zinc treatment alters the mechanical properties and metabolism of prostate cancer cells;Cancer Cell International;2024-09-11

3. Immunoproteasome acted as immunotherapy ‘coffee companion’ in advanced carcinoma therapy;Frontiers in Immunology;2024-08-30

4. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation;eLife;2024-07-08

5. ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response;Nature Metabolism;2024-06-10